StreetInsider.com News Articles

Form 4 ORTHOPEDIATRICS CORP For: Sep 10 Filed by: Pelizzon David R

Thu, 10 Sep 2026 16:21:00 -0400

si-local-file:///var/storage/secattach/20260910/27048736.html

Form 4 ORTHOPEDIATRICS CORP For: Aug 24 Filed by: Pritzker Jennifer N.

Wed, 26 Aug 2026 18:31:00 -0400

si-local-file:///var/storage/secattach/20260826/26983126.html

Form 4 ORTHOPEDIATRICS CORP For: Aug 24 Filed by: Pritzker Jennifer N.

Wed, 26 Aug 2026 18:31:00 -0400

si-local-file:///var/storage/secattach/20260826/26983126.html

Form 4 ORTHOPEDIATRICS CORP For: Aug 24 Filed by: Squadron Capital LLC

Wed, 26 Aug 2026 18:29:00 -0400

si-local-file:///var/storage/secattach/20260826/26983123.html

Form 4 ORTHOPEDIATRICS CORP For: Aug 24 Filed by: Squadron Capital LLC

Wed, 26 Aug 2026 18:29:00 -0400

si-local-file:///var/storage/secattach/20260826/26983123.html

Form 4 ORTHOPEDIATRICS CORP For: Aug 24 Filed by: Pelizzon David R

Wed, 26 Aug 2026 18:18:00 -0400

si-local-file:///var/storage/secattach/20260826/26983097.html

Form 4 ORTHOPEDIATRICS CORP For: Aug 24 Filed by: Pelizzon David R

Wed, 26 Aug 2026 18:18:00 -0400

si-local-file:///var/storage/secattach/20260826/26983097.html

OrthoPediatrics launches pediatric hip plating system after 350 implants

Tue, 25 Aug 2026 07:05:11 -0400

OrthoPediatrics Corp. (Nasdaq: KIDS) announced the full commercial launch of its 3P Pediatric Plating Platform Hip System, following a limited launch period that included more than 350 surgical implantations across the United States.

The system is now broadly available to pediatric orthopedic surgeons nationwide. According to the company, the 3P Hip System is the first product within its broader Pediatric Plating Platform portfolio and is designed for the treatment of proximal femur trauma and deformities.

The system includes Locking Proximal Femur Plates and Beam Screw constructs available in Infant, Child, and Adolescent configurations. OrthoPediatrics states the platform was designed to provide enhanced

OrthoPediatrics Announces Full Commercial Launch of 3P™ Pediatric Plating Platform® Hip System Following More Than 350 Successful Implantations

Tue, 25 Aug 2026 07:05:00 -0400

Successful Limited Launch Demonstrates Demand for Innovative Pediatric-Specific Hip Plating Technology

WARSAW, Ind., Aug. 25, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the full commercial launch of its 3P™ Pediatric Plating Platform^® Hip System.

Following a highly successful limited launch period that resulted in over 350 surgical implantations, the system is now broadly available to pediatric orthopedic surgeons throughout the United States. The 3P Hip System is the first system within the Company's broader Pediatric Plating Platform portfolio and represents a

OrthoPediatrics Announces Full Commercial Launch of 3P™ Pediatric Plating Platform® Hip System Following More Than 350 Successful Implantations

Tue, 25 Aug 2026 07:05:00 -0400

Successful Limited Launch Demonstrates Demand for Innovative Pediatric-Specific Hip Plating Technology

Form 144 ORTHOPEDIATRICS CORP Filed by: Squadron Capital LLC

Mon, 24 Aug 2026 16:33:00 -0400

si-local-file:///var/storage/secattach/20260824/26968558.html

Form 144 ORTHOPEDIATRICS CORP Filed by: Squadron Capital LLC

Mon, 24 Aug 2026 16:33:00 -0400

si-local-file:///var/storage/secattach/20260824/26968558.html

Form 10-Q ORTHOPEDIATRICS CORP For: Jun 30

Wed, 05 Aug 2026 13:56:00 -0400

si-local-file:///var/storage/secattach/20260805/26872913.html

Form 10-Q ORTHOPEDIATRICS CORP For: Jun 30

Wed, 05 Aug 2026 13:56:00 -0400

si-local-file:///var/storage/secattach/20260805/26872913.html

OrthoPediatrics Corp. (KIDS) PT Raised to $24 at Stifel

Wed, 05 Aug 2026 08:21:20 -0400

Stifel analyst Rick Wise raised the price target on OrthoPediatrics Corp. (NASDAQ: KIDS) to $24.00 (from $22.00) while maintaining a Buy rating.

OrthoPediatrics Corp. (KIDS) PT Raised to $25 at Piper Sandler

Wed, 05 Aug 2026 07:03:08 -0400

Piper Sandler analyst Matt O'Brien raised the price target on OrthoPediatrics Corp. (NASDAQ: KIDS) to $25.00 (from $22.00) while maintaining a Overweight rating.

OrthoPediatrics (KIDS) Reports In-Line Q2 EPS

Tue, 04 Aug 2026 17:48:46 -0400

OrthoPediatrics (NASDAQ: KIDS) reported Q2 EPS of ($0.30), in-line with the analyst estimate of ($0.30). Revenue for the quarter came in at $70.51 million versus the consensus estimate of $68.22 million.

For earnings history and earnings-related data on OrthoPediatrics (KIDS) click here.

Form 8-K ORTHOPEDIATRICS CORP For: Aug 04

Tue, 04 Aug 2026 16:32:00 -0400

si-local-file:///var/storage/secattach/20260804/26867110.html

Form 8-K ORTHOPEDIATRICS CORP For: Aug 04

Tue, 04 Aug 2026 16:32:00 -0400

si-local-file:///var/storage/secattach/20260804/26867110.html

Form 8-K ORTHOPEDIATRICS CORP For: Aug 04

Tue, 04 Aug 2026 16:08:00 -0400

si-local-file:///var/storage/secattach/20260804/26866269.html

Form 8-K ORTHOPEDIATRICS CORP For: Aug 04

Tue, 04 Aug 2026 16:08:00 -0400

si-local-file:///var/storage/secattach/20260804/26866269.html

OrthoPediatrics Corp. Reports Second Quarter 2026 Financial Results and Increases 2026 Financial Guidance

Tue, 04 Aug 2026 16:05:00 -0400

Second Quarter 2026 Revenue Surpasses $70 million for the First Time in Company History, and Increased 15% Year-over-Year

WARSAW, Ind., Aug. 04, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its financial results for the second quarter ended June 30, 2026.

Second Quarter 2026 and Business Highlights

Helped a record of nearly 46,000 children in the second quarter of 2026
Generated new record high total revenue of $70.5 million for the second quarter of 2026, up

OrthoPediatrics Corp. Reports Second Quarter 2026 Financial Results and Increases 2026 Financial Guidance

Tue, 04 Aug 2026 16:05:00 -0400

Second Quarter 2026 Revenue Surpasses $70 million for the First Time in Company History, and Increased 15% Year-over-Year

Second Quarter 2026 and Business Highlights

Helped a record of nearly 46,000 children in the second quarter of 2026
Generated new record high total revenue of $70.5 million for the second quarter of 2026, up

OrthoPediatrics to Participate in the Canaccord Genuity 46th Annual Growth Conference

Wed, 29 Jul 2026 16:05:00 -0400

WARSAW, Ind., July 29, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that Dave Bailey, President & Chief Executive Officer, and Fred Hite, Chief Operating Officer, and Chief Financial Officer, are scheduled to participate in a fireside chat at the Canaccord Genuity 46^th Annual Growth Conference, held in Boston, MA.

Event: Canaccord Genuity 46^th Annual Growth Conference
Format: Fireside Chat
Date: Wednesday, August 12, 2026
Time: 9:00 am ET

An audio webcast of the discussion will be

OrthoPediatrics to Participate in the Canaccord Genuity 46th Annual Growth Conference

Wed, 29 Jul 2026 16:05:00 -0400

Event: Canaccord Genuity 46^th Annual Growth Conference
Format: Fireside Chat
Date: Wednesday, August 12, 2026
Time: 9:00 am ET

An audio webcast of the discussion will be